These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
92 related articles for article (PubMed ID: 28253714)
1. Microarray expression analysis of MYCN-amplified neuroblastoma cells after inhibition of CDK2. Song H; Wu F; Li S; Wang Z; Liu X; Cui Y; Lin C Neoplasma; 2017; 64(3):351-357. PubMed ID: 28253714 [TBL] [Abstract][Full Text] [Related]
2. Bioinformatics analysis of the CDK2 functions in neuroblastoma. Bo L; Wei B; Wang Z; Kong D; Gao Z; Miao Z Mol Med Rep; 2018 Mar; 17(3):3951-3959. PubMed ID: 29328425 [TBL] [Abstract][Full Text] [Related]
3. Identification of potential therapeutic targets for colorectal cancer by bioinformatics analysis. Yan M; Song M; Bai R; Cheng S; Yan W Oncol Lett; 2016 Dec; 12(6):5092-5098. PubMed ID: 28105216 [TBL] [Abstract][Full Text] [Related]
4. Microarray data analysis of neuroblastoma: Expression of SOX2 downregulates the expression of MYCN. Bao J; Qin L; Cui L; Wang X; Meng Q; Zhu L; Zhang S Mol Med Rep; 2015 Nov; 12(5):6867-72. PubMed ID: 26398570 [TBL] [Abstract][Full Text] [Related]
5. Identification of Key Pathways and Genes in Anaplastic Thyroid Carcinoma via Integrated Bioinformatics Analysis. Hu S; Liao Y; Chen L Med Sci Monit; 2018 Sep; 24():6438-6448. PubMed ID: 30213925 [TBL] [Abstract][Full Text] [Related]
6. Identification of genes and pathways associated with pancreatic ductal adenocarcinoma by bioinformatics analyses. Long J; Zhang Z; Liu Z; Xu Y; Ge C Oncol Lett; 2016 Feb; 11(2):1391-1397. PubMed ID: 26893748 [TBL] [Abstract][Full Text] [Related]
7. Upregulated cyclins may be novel genes for triple-negative breast cancer based on bioinformatic analysis. Lu Y; Yang G; Xiao Y; Zhang T; Su F; Chang R; Ling X; Bai Y Breast Cancer; 2020 Sep; 27(5):903-911. PubMed ID: 32338339 [TBL] [Abstract][Full Text] [Related]
8. Effects of β-catenin on differentially expressed genes in multiple myeloma. Chen H; Chai W; Li B; Ni M; Zhang GQ; Liu HW; Zhang Z; Chen JY; Zhou YG; Wang Y J Huazhong Univ Sci Technolog Med Sci; 2015 Aug; 35(4):546-552. PubMed ID: 26223925 [TBL] [Abstract][Full Text] [Related]
9. Identification of candidate biomarkers and pathways associated with SCLC by bioinformatics analysis. Wen P; Chidanguro T; Shi Z; Gu H; Wang N; Wang T; Li Y; Gao J Mol Med Rep; 2018 Aug; 18(2):1538-1550. PubMed ID: 29845250 [TBL] [Abstract][Full Text] [Related]
10. Identification of potential targets for ovarian cancer treatment by systematic bioinformatics analysis. Ye Q; Lei L; Aili AX Eur J Gynaecol Oncol; 2015; 36(3):283-9. PubMed ID: 26189254 [TBL] [Abstract][Full Text] [Related]
11. Bioinformatics analysis shows that TOP2A functions as a key candidate gene in the progression of cervical cancer. Zhao Q; Li H; Zhu L; Hu S; Xi X; Liu Y; Liu J; Zhong T Biomed Rep; 2020 Oct; 13(4):21. PubMed ID: 32765860 [TBL] [Abstract][Full Text] [Related]
12. Bioinformatical Analysis of Gene Expression Omnibus Database Associates TAF7/CCNB1, TAF7/CCNA2, and GTF2E2/CDC20 Pathways with Glioblastoma Development and Prognosis. Yang L; Zeng W; Sun H; Huang F; Yang C; Cai X; Lu Y; Zeng J; Yang K World Neurosurg; 2020 Jun; 138():e492-e514. PubMed ID: 32147549 [TBL] [Abstract][Full Text] [Related]
13. Molecular mechanisms underlying gliomas and glioblastoma pathogenesis revealed by bioinformatics analysis of microarray data. Vastrad B; Vastrad C; Godavarthi A; Chandrashekar R Med Oncol; 2017 Sep; 34(11):182. PubMed ID: 28952134 [TBL] [Abstract][Full Text] [Related]
14. Key signaling pathways, genes and transcription factors associated with hepatocellular carcinoma. Wang J; Tian Y; Chen H; Li H; Zheng S Mol Med Rep; 2018 Jun; 17(6):8153-8160. PubMed ID: 29658607 [TBL] [Abstract][Full Text] [Related]
15. Identification of potential therapeutic target genes and mechanisms in non-small-cell lung carcinoma in non-smoking women based on bioinformatics analysis. Zhou W; Yin M; Cui H; Wang N; Zhao LL; Yuan LZ; Yang XP; Ding XM; Men FZ; Ma X; Na JR Eur Rev Med Pharmacol Sci; 2015 Sep; 19(18):3375-84. PubMed ID: 26439031 [TBL] [Abstract][Full Text] [Related]
16. Investigation of crucial genes and microRNAs in conventional osteosarcoma using gene expression profiling analysis. Peng C; Yang Q; Wei B; Yuan B; Liu Y; Li Y; Gu D; Yin G; Wang B; Xu D; Zhang X; Kong D Mol Med Rep; 2017 Nov; 16(5):7617-7624. PubMed ID: 28944822 [TBL] [Abstract][Full Text] [Related]
17. Inhibition of cyclin-dependent kinase 1-induced cell death in neuroblastoma cells through the microRNA-34a-MYCN-survivin pathway. Chen Y; Tsai YH; Tseng SH Surgery; 2013 Jan; 153(1):4-16. PubMed ID: 22703967 [TBL] [Abstract][Full Text] [Related]
18. Bioinformatics analysis of gene expression profiles of esophageal squamous cell carcinoma. He Y; Liu J; Zhao Z; Zhao H Dis Esophagus; 2017 May; 30(5):1-8. PubMed ID: 28375447 [TBL] [Abstract][Full Text] [Related]
19. Sensitivity to cdk1-inhibition is modulated by p53 status in preclinical models of embryonal tumors. Schwermer M; Lee S; Köster J; van Maerken T; Stephan H; Eggert A; Morik K; Schulte JH; Schramm A Oncotarget; 2015 Jun; 6(17):15425-35. PubMed ID: 26029996 [TBL] [Abstract][Full Text] [Related]
20. Integrative omics reveals MYCN as a global suppressor of cellular signalling and enables network-based therapeutic target discovery in neuroblastoma. Duffy DJ; Krstic A; Halasz M; Schwarzl T; Fey D; Iljin K; Mehta JP; Killick K; Whilde J; Turriziani B; Haapa-Paananen S; Fey V; Fischer M; Westermann F; Henrich KO; Bannert S; Higgins DG; Kolch W Oncotarget; 2015 Dec; 6(41):43182-201. PubMed ID: 26673823 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]